Table 1.

Clinical patient data extracted from the six harmonized published datasets integrated in the PDAC atlas.

	Peng et al	Steele et al	Lin et al	Elyada et al	Moncada et al	Bernard et al
Year of publication	2019	2020	2020	2019	2020	2019
Country of enrollment	China	USA	South Korea, USA	USA	USA	USA
PDAC pancreas tissue samples
Treatment-naïve, %	100%	100%	100%	100%	100%	100%
Patients, N	24	16	10	6	3	2
Sex, N
Female	13	6	4	2	Unknown	0
Male	11	10	6	4	Unknown	2
Age, years median (range)	59 (36–72)	66 (42–80)	66 (41–80)	73 (64–87)	Unknown	61 (59–62)
Diabetes, N	10	6	Unknown	Unknown	Unknown	Unknown
Staging, N
Localized	24	12	10	5	Unknown	1
Metastatic	0	4	0	1	Unknown	1
Grading, N
Well differentiated	3	Unknown	0	0	Unknown	0
Moderately differentiated	8	≥6	6	3	Unknown	0
Poorly differentiated	13	Unknown	2	3	Unknown	2
Anaplastic	0	Unknown	2	0	Unknown	0
Tumor location, N
Head or uncinate	15	Unknown	Unknown	Unknown	Unknown	1
Neck, body or tail	9	Unknown	Unknown	Unknown	Unknown	1
Specimen, N
Surgery (resected)	24	6	10	6	3	2
Biopsy (FNA)	0	10	0	0	0	0
Survival	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown
Non-malignant pancreas tissue samples
Patients, N	11	3	0	2	0	0
Sex, N
Female	6	2	---	1	---	---
Male	5	1	---	1	---	---
Histology, N
Normal	10	1	---	0	---	---
Normal-adjacent to adenocarcinoma	1	2	---	2	---	---
Specimen, N
Surgery (resected)	11	3	---	2	---	---
Biopsy (EUS-FNA)	0	0	---	0	---	---

PDAC, pancreatic ductal adenocarcinoma

EUS-FNA, endoscopic ultrasound guided-fine needle aspiration